Predicting Chest Wall Pain From Lung Stereotactic Body Radiotherapy for Different Fractionation Schemes

被引:43
|
作者
Woody, Neil M. [1 ]
Videtic, Gregory M. M. [1 ]
Stephans, Kevin L. [1 ]
Djemil, Toufik [1 ]
Kim, Yongbok [2 ]
Xia, Ping [1 ]
机构
[1] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Ctr, Cleveland, OH 44195 USA
[2] Allegheny Gen Hosp, Dept Radiat Oncol, Pittsburgh, PA 15212 USA
关键词
Stereotactic body radiation therapy; Chest wall pain; Modified effective uniform dose; Stage I lung cancer; Radiobiologic effect; RADIATION-THERAPY; CANCER; TRIAL;
D O I
10.1016/j.ijrobp.2011.06.1971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recent studies with two fractionation schemes predicted that the volume of chest wall receiving >30 Gy (V30) correlated with chest wall pain after stereotactic body radiation therapy (SBRT) to the lung. This study developed a predictive model of chest wall pain incorporating radiobiologic effects, using clinical data from four distinct SBRT fractionation schemes. Methods and Materials: 102 SBRT patients were treated with four different fractionations: 60 Gy in three fractions, 50 Gy in five fractions, 48 Gy in four fractions, and 50 Gy in 10 fractions. To account for radiobiologic effects, a modified equivalent uniform dose (mEUD) model calculated the dose to the chest wall with volume weighting. For comparison, V30 and maximum point dose were also reported. Using univariable logistic regression, the association of radiation dose and clinical variables with chest wall pain was assessed by uncertainty coefficient (U) and C statistic (C) of receiver operator curve. The significant associations from the univariable model were verified with a multivariable model. Results: 106 lesions in 102 patients with a mean age of 72 were included, with a mean of 25.5 (range, 12-55) months of follow-up. Twenty patients reported chest wall pain at a mean time of 8.1 (95% confidence interval, 6.3-9.8) months after treatment. The mEUD models, V30, and maximum point dose were significant predictors of chest wall pain (p < 0.0005). mEUD improved prediction of chest wall pain compared with V30 (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.11). The mEUD with moderate weighting (a = 5) better predicted chest wall pain than did mEUD without weighting (a = 1) (C = 0.79 vs. 0.77 and U = 0.16 vs. 0.14). Body mass index (BMI) was significantly associated with chest wall pain (p = 0.008). On multivariable analysis, mEUD and BMI remained significant predictors of chest wall pain (p = 0.0003 and 0.03, respectively). Conclusion: mEUD with moderate weighting better predicted chest wall pain than did V30, indicating that a small chest wall volume receiving a high radiation dose is responsible for chest wall pain. Independently of dose to the chest wall, BMI also correlated with chest wall pain. (C) 2012 Elsevier Inc.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 50 条
  • [31] Stereotactic body radiotherapy for adrenal metastases from lung cancer
    Guiou, Michael
    Mayr, Nina A.
    Kim, Edward Y.
    Williams, Terence
    Lo, Simon S.
    JOURNAL OF RADIATION ONCOLOGY, 2012, 1 (02) : 155 - 163
  • [32] Chest wall pain following lung stereotactic body radiation therapy using 48 Gy in three fractions: A search for predictors
    Albers, J.
    Parker, W.
    Kildea, J.
    Pembroke, C.
    Faria, S.
    CANCER RADIOTHERAPIE, 2019, 23 (02): : 98 - 103
  • [33] Low Incidence of Chest Wall Pain with a Risk-Adapted Lung Stereotactic Body Radiation Therapy Approach Using Three or Five Fractions Based on Chest Wall Dosimetry
    Coroller, Thibaud P.
    Mak, Raymond H.
    Lewis, John H.
    Baldini, Elizabeth H.
    Chen, Aileen B.
    Colson, Yolonda L.
    Hacker, Fred L.
    Hermann, Gretchen
    Kozono, David
    Mannarino, Edward
    Molodowitch, Christina
    Wee, Jon O.
    Sher, David J.
    Killoran, Joseph H.
    PLOS ONE, 2014, 9 (04):
  • [34] Linear-Quadratic Dose Correction for Chest Wall Pain in Thoracic Stereotactic Body Radiation
    Williams, E. L.
    Din, S. U.
    Yorke, E. D.
    Wu, A. J.
    Foster, A. J.
    Rosenzweig, K. E.
    Rimner, A.
    Jackson, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S54 - S54
  • [35] Chest Wall Dosimetry Using Non-Coplanar Volumetric Modulated Arc Radiotherapy for Lung Stereotactic Ablative Radiotherapy
    Yu, Amy S.
    Maxim, P.
    Gensheimer, M.
    MEDICAL PHYSICS, 2017, 44 (06) : 2963 - 2964
  • [36] Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative Radiotherapy
    Chaudhuri, Aadel A.
    Binkley, Michael S.
    Aggarwal, Sonya
    Qian, Yushen
    Carter, Justin N.
    Shah, Rajesh
    Loo, Billy W., Jr.
    CUREUS, 2016, 8 (02):
  • [37] Stereotactic body radiotherapy for oligometastatic lung tumors
    Norihisa, Yoshiki
    Nagata, Yasushi
    Takayama, Kenji
    Matsuo, Yukinori
    Sakamoto, Takashi
    Sakamoto, Masato
    Mizowaki, Takashi
    Yano, Shinsuke
    Hiraoka, Masahiro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 398 - 403
  • [38] Editorial: Stereotactic body radiotherapy for lung cancer
    Liu, An
    Kroeze, Stephanie G. C.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC LUNG TUMORS
    Beltramo, G.
    Bianchi, L. C.
    Bergantin, A.
    Martinotti, A. S.
    Bonfanti, P.
    Gerosa, C.
    Varoli, F.
    Locatelli, M. C.
    Mariani, P.
    LUNG CANCER, 2011, 71 : S45 - S45
  • [40] STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC DISEASE TO THE LUNG
    Ashman, Jonathan
    Goyal, Uma
    Vora, Sujay
    Clouser, Edward
    Jaroszewski, Dawn
    Dueck, Amylou
    Paripati, Harshita
    Wesselius, Lewis
    Rule, William
    Ross, Helen J.
    Schild, Steve
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1138 - S1138